Cost-Benefit Analysis of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis
Year: 1997
Type: article
Source: PharmacoEconomics
Authors: Gary M. Ginsberg, Boaz Lev
Institution: Israel Ministry of Health
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2047448682
